#biomarkers

Researchers at Örebro University have identified anti-integrin αvβ6 antibodies in blood samples that can flag individuals at risk of developing ulcerative colitis long before any symptoms manifest. The discovery could enable earlier interventions and potentially delay the onset of this debilitating inflammatory bowel disease.

Researchers identify miR-149-5p as a key driver of immune escape in bronchial lesions that can progress to squamous cell lung cancer.

A multi-omics approach achieves 92% accuracy in forecasting organ failure and mortality in trauma patients, days before symptoms appear.

Researchers identify blood-based biomarkers that forecast trauma patient outcomes days before clinical signs appear, transforming critical care.